Peter S. Klein's most recent trade in Denali Therapeutics Inc was a trade of 18,111 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 27,533 (0%) | 0% | 0 | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Apr 2025 | 35,021 | 0 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Sale or transfer of securities back to the company at price $ 7.03 per share. | 08 Apr 2025 | 28,329 | 0 | - | 7.0 | 199,153 | Common Stock |
| Accolade Inc | Peter S. Klein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Apr 2025 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Accolade Inc | Peter S. Klein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Apr 2025 | 8,600 | 0 | - | - | Stock Option (Right to Buy) | |
| F5 | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 1,309 | 13,333 (0%) | 0% | 0 | Common Stock | |
| F5 | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 1,309 | 0 | - | - | Restricted Stock Unit | |
| F5 | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 934 | 934 | - | - | Restricted Stock Unit | |
| F5 | Peter S. Klein | Director | 05 Sep 2024 | 1,000 | 12,024 (0%) | 0% | 0 | Common Stock | ||
| Accolade Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 35,021 | 35,021 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 9,196 | 0 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 9,196 | 28,329 | - | - | Common Stock | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 21,496 (0%) | 0% | 0 | Common Stock | |
| F5 | Peter S. Klein | Director | 13 Mar 2024 | 1,770 | 0 | - | - | Restricted Stock Unit | ||
| F5 | Peter S. Klein | Director | 13 Mar 2024 | 1,770 | 13,024 (0%) | 0% | 0 | Common Stock | ||
| F5 | Peter S. Klein | Director | 13 Mar 2024 | 1,309 | 1,309 | - | - | Restricted Stock Unit | ||
| Accolade Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2023 | 9,196 | 9,196 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 14,060 | 0 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 14,060 | 19,133 | - | - | Common Stock | |
| Sarcos Technology and Robo... | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 195,059 | 265,066 | - | 0 | Common Stock | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 15,529 (0%) | 0% | 0 | Common Stock | |
| F5 | Peter S. Klein | Director | 08 Mar 2023 | 1,770 | 1,770 | - | - | Restricted Stock Unit | ||
| F5 | Peter S. Klein | Director | 08 Mar 2023 | 1,272 | 0 | - | - | Restricted Stock Unit | ||
| F5 | Peter S. Klein | Director | 08 Mar 2023 | 1,272 | 12,454 (0%) | 0% | 0 | Common Stock | ||
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 604 | 0 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 604 | 5,073 | - | - | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 603 | 4,469 | - | - | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 603 | 604 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2022 | 604 | 1,207 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2022 | 604 | 3,866 | - | - | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 14,060 | 14,060 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.67 per share. | 21 Jul 2022 | 2,659 | 3,262 | - | 9.7 | 25,713 | Common Stock |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2022 | 2,659 | 0 | - | - | Restricted Stock Units | |
| Sarcos Technology and Robo... | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 57,692 | 70,007 | - | 0 | Common Stock | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,959 | 17,959 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,986 | 11,313 (0%) | 0% | 0 | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 603 | 1,811 | - | - | Restricted Stock Units | |
| Accolade Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 603 | 603 | - | - | Common Stock | |
| F5 | Peter S. Klein | Director | 09 Mar 2022 | 1,282 | 11,182 (0%) | 0% | 0 | Common Stock | ||
| F5 | Peter S. Klein | Director | 09 Mar 2022 | 1,282 | 0 | - | - | Restricted Stock Unit | ||
| F5 | Peter S. Klein | Director | 09 Mar 2022 | 1,272 | 1,272 | - | - | Restricted Stock Unit | ||
| Accolade Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,414 | 2,414 | - | - | Restricted Stock Units | |
| Sarcos Technology and Robo... | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 12,315 | 12,315 | - | 0 | Common Stock | |
| Accolade Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 2,659 | 2,659 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,222 | 6,222 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,074 | 5,327 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 3,253 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 0 | - | - | Restricted Stock Units | |
| F5 | Peter S. Klein | Director | 11 May 2021 | 1,000 | 9,900 (0%) | 0% | 0 | Common Stock | ||
| F5 | Peter S. Klein | Director | 10 Mar 2021 | 2,543 | 10,900 (0%) | 0% | 0 | Common Stock | ||
| F5 | Peter S. Klein | Director | 10 Mar 2021 | 2,543 | 0 | - | - | Restricted Stock Unit | ||
| F5 | Peter S. Klein | Director | 10 Mar 2021 | 1,282 | 1,282 | - | - | Restricted Stock Unit |